Global Bronchitis Treatment Market Size (2024 - 2029)

Bronchitis Treatment Market Analysis

The bronchitis treatment market is expected to grow at a CAGR of 3.6% over the forecast period (2022-2027).

The onset of the COVID-19 pandemic has led to a reduction in the number of patient visits that reduced the number of patients opting for bronchitis treatment, thereby impacting the market growth. For instance, as per a September 2020 published article titled, "Reduction in ambulatory visits for acute, uncomplicated bronchitis: an unintended but welcome result of the coronavirus disease 2019 (COVID-19) pandemic", the COVID-19 pandemic, while challenging for so many other aspects of antimicrobial stewardship, has led to an overall net reduction in ambulatory adults seeking care for bronchitis in the health system and has resulted in a dramatic reduction in antibiotic prescriptions for the condition. As a result, the impact of COVID-19 on the market was adverse during the initial phase of the pandemic.

Further, the major factors fueling the market's growth are the rise in the geriatric population with an augmented incidence of bronchitis, the growing prevalence of chronic obstructive pulmonary disease (COPD), an upsurge in the smoking populace, and rising levels of chemical pollutants.

The increased prevalence of COPD is a major factor driving the market growth. For instance, as per the House of Commons 2022, NHS Digital data shows that in 2020-2021, approximately 1.17 million people in England have been diagnosed with COPD, which is around 1.9% of the population. Also, as per a June 2021 update by the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Thus, the increasing burden of COPD is leading to increasing demand for bronchitis treatment, as chronic bronchitis is one of the most common conditions leading to COPD, thereby contributing to the market growth.

However, the patent expiry of key drugs is a major factor hindering the bronchitis treatment market's growth.

Bronchitis Treatment Industry Segmentation

As per the scope of the report, bronchitis is an inflammation of the lining of bronchial tubes, which is associated with coughing up thickened mucus, which can be discolored. The bronchitis treatment market is segmented by class of drugs (antibiotics, anti-inflammatory drugs, bronchodilators, and other drugs), end user (hospital pharmacies, retail pharmacies, and other end users), type (acute bronchitis and chronic bronchitis), and geography (North America, Europe, Asia-Pacific, Middle East, and Africa and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.